Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 6) Regulations 2020

JurisdictionIreland
CitationIR SI 614/2020
Year2020

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of 22nd December, 2020.

I, STEPHEN DONNELLY, Minister for Health, in exercise of the powers conferred on me by section 32 (as amended by section 16 of the Irish Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines Board Act 1995 (No. 29 of 1995), hereby make the following regulations:

1. (1) These Regulations may be cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 6) Regulations 2020.

(2) The citation “the Medicinal Products (Prescription and Control of Supply) Regulations 2003 to 2020” includes these Regulations.

2. These regulations shall come into operation on 1 January 2021.

3. In these Regulations—

“Principal Regulations” means the Medicinal Products (Prescription and Control of Supply) Regulations 2003 ( S.I. No. 540 of 2003 );

“Regulations of 2014” means the Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 2) Regulations 2014 ( S.I. No. 504 of 2014 );

“Regulations of 2015” means the Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2015 ( S.I. No. 87 of 2015 );

“Regulations of 2020” means the Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2020 ( S.I. No. 98 of 2020 ).

4. Regulation 4(1) (as amended by Regulation 3 of the Regulations of 2020) of the Principal Regulations is amended—

(a) by inserting after the definition of “hospital” the following definition:

“‘information society services’ has the meaning assigned to it by Directive (EU) 2015/1535 of the European Parliament and of the Council of 9 September 20151 ;”, and

(b) in the definition of “prescription”—

(i) in subparagraph (c), by deleting “or”,

(ii) in subparagraph (d), by substituting “order, or” for “order;”, and

(iii) by inserting after subparagraph (d) the following subparagraph:

“(e) a practitioner, of status equivalent to a registered medical practitioner, a registered dentist or a registered nurse, practising in the United Kingdom, who is legally entitled to issue a prescription for the medicinal product concerned in the United Kingdom, if the prescription has not been issued with a view to enabling the supply of a medicinal product by mail order and the prescription has not been issued by means of information society services;”.

5. Regulation 7(1A) (inserted by Regulation 4 of the Regulations of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT